Newborn infants have relatively low levels of circulating 5-hydroxytryptamine (5HT, serotonin) when compared with adults or children (Mitchell and Cass, 1959; Hazra, Benson, and Sandler, 1965) . Values in cord blood are similarly low (R. S. Stacey, 1965, personal communication) . Berman, Justice, and Hsia (1965) have confirmed these findings in low birth weight and full-term newborn infants and have shown in common with Hazra et al. that 5HT concentration rises slowly after birth, to reach the adult level during the first month of life. They further demonstrated that these values could be rapidly increased during the first few days of life by the administration of pyridoxine (vitamin B6).
The present study was undertaken to determine whether a similar rise occurs in the newborn infant, if vitamin B6 is given to the mother during the final three to five weeks of gestation.
Subjects and Methods
The patients taking part in the study consisted After delivery it was ascertained by direct questioning that each woman had in fact taken the tablets each day. Two mothers were excluded from the study because of severe pre-eclamptic toxaemia, and 17 mothers and infants were excluded for a variety of technical reasons. Thus 40 mothers and infants remained in the study.
Venous blood was collected from the cord of each infant and analysed for 5HT according to the method of Contractor (1964) . When feasible, a 24-hour urine sample was collected and assayed for 5-hydroxyindoleacetic acid (5HIAA) by the method of Udenfriend, Titus, and Weissbach (1955) . Such urine samples were obtained during the first 48 hours of life from 28 infants.
Maternal blood samples for 5HT estimation were collected on three different occasions: at initial examination; during the second stage of labour; and 8-10 days after delivery before the patient left hospital. In addition 33 women had platelet counts performed on initial and post-partum blood samples.
Results
Mean values for cord blood 5HT and urinary 5HIAA are shown in Table I . There was no significant difference between test and control groups. 5HT levels in women receiving pyridoxine did not differ significantly from the control group at any of the times tested (Table II) . However, within each group, values rose significantly between initial and post-partum samplings. In addition, in groups B and C, a significant rise was also found between initial and parturition samples.
Platelet counts tended to rise during the postpartum period in all groups (Table II) . However, this rise did not reach significance. There was no correlation between cord blood 5HT and urinary 5HIAA nor any correlation between either of these and maternal 5HT or platelets. Maternal age, birth weight, and Apgar scores were also unrelated to cord blood 5HT. Wachstein, Kellner, and Ortiz (1960) have demonstrated that such deficiency in pregnant women can readily be corrected by the administration of 2-25 mg. B6 per day.
Pyridoxine presumably crosses the placenta in amounts sufficient for the infant's needs; in fact, levels are normally higher in the cord than in maternal blood (Wachstein et al., 1960; Karlin and Dumont, 1963) and can be further increased by tryptophan 5-h ydroxyt ryptophan maternal pyridoxine supplementation (Coursin and Brown, 1961) . In addition, the fall usually observed in infant blood levels during the first 24 hours of life does not occur in the infants of mothers who have received supplementary vitamin B6 (Coursin and Brown, 1961) . Many enzyme systems are immature during the foetal and newborn periods of life (Driscoll and Hsia, 1958) . Among these, 5HTPD activity has been found to be low or absent in newborn and foetal rat kidneys (Huang, Tannenbaum, and Hsia, 1960; Smith, Stacey, and Young, 1962; Berman et al., 1965) and in rat brain (Nachmias, 1960) . It is thus possible that the inability of vitamin B6 to raise cord levels of 5HT is due to a marked though physiological deficiency of 5HTPD.
A possible alternative explanation stems from the finding that a variety of hormones can interfere with pyridoxine-dependent enzymes (Yamada, Yazaki, Sawaki, and Utumi, 1958; Jolles-Bergeret, LaBouesse, and Chatagner, 1960; Scardi, Iaccarino, and Scarano, 1962) . In particular, Mason and Schirch (1961) have shown that oestrogens will inhibit 5HTPD in vitro. Should such inhibition occur in vivo, it may be that high circulating maternal oestrogen levels antagonize any ability pyridoxine possesses to prime the 5HTPD system.
A rise in maternal 5HT was noted in groups B and C at parturition, but not in group A. During the post-partum period both control and supplemented groups showed a significant rise; similar results have been obtained by S. F. Contractor and M. Sandler (personal communication, 1965) . Virtually all circulating 5HT is contained in blood platelets group.bmj.com on April 12, 2017 -Published by http://adc.bmj.com/ Downloaded from Effect of Maternal Pyridoxine Ingestion on Cord Blood 5-Hydroxytryptamine Concentration 53 (Stacey, 1958) , but since platelet counts did not change significantly during the period of the investigation, an explanation must be sought elsewhere.
Vitamin B6 deficiency causes a decrease of available pyridoxal-5-phosphate and a depression of 5HTPD activity which is corrected by its administration (Buzard and Nytch, 1957; Pogrund, Drell, and Clark, 1961) . This may explain why the supplemented groups were able to increase their 5HT levels at parturition. A further availability of dietary vitamin B6 to the mother would occur during the post-partum period when the foetus made no further demands. It would be interesting, however, if an alternative explanation were eventually to be found in terms of release of 5HTPD from inhibition by circulating oestrogens.
Summary
Neither cord blood 5-hydroxytryptamine level nor urinary 5-hydroxyindoleacetic acid output in the newborn infant can be increased by maternal ingestion of pyridoxine during the last 3 to 5 weeks of pregnancy. Previous work had shown an increase after direct administration of the vitamin to the newborn infant.
Increased maternal blood levels of 5HT were found in both test and control groups during the post-partum period, but only in test groups at parturition. The possible implications of these results are discussed in terms of relative pyridoxine deficiency and 5-hydroxytryptophan decarboxylase maturity.
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